ATE143257T1 - Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung - Google Patents

Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung

Info

Publication number
ATE143257T1
ATE143257T1 AT90916175T AT90916175T ATE143257T1 AT E143257 T1 ATE143257 T1 AT E143257T1 AT 90916175 T AT90916175 T AT 90916175T AT 90916175 T AT90916175 T AT 90916175T AT E143257 T1 ATE143257 T1 AT E143257T1
Authority
AT
Austria
Prior art keywords
delivery system
drug delivery
active substances
production
matrix
Prior art date
Application number
AT90916175T
Other languages
English (en)
Inventor
Torsten Fjellstroem
Original Assignee
Medinvent Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinvent Sa filed Critical Medinvent Sa
Application granted granted Critical
Publication of ATE143257T1 publication Critical patent/ATE143257T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Or Creating Images (AREA)
  • Image Processing (AREA)
AT90916175T 1989-10-23 1990-10-22 Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung ATE143257T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903503A SE465950B (sv) 1989-10-23 1989-10-23 Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning

Publications (1)

Publication Number Publication Date
ATE143257T1 true ATE143257T1 (de) 1996-10-15

Family

ID=20377242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916175T ATE143257T1 (de) 1989-10-23 1990-10-22 Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung

Country Status (9)

Country Link
US (1) US5614221A (de)
EP (1) EP0497846B1 (de)
JP (1) JP3017801B2 (de)
AT (1) ATE143257T1 (de)
AU (1) AU632634B2 (de)
CA (1) CA2067228C (de)
DE (1) DE69028710T2 (de)
SE (1) SE465950B (de)
WO (1) WO1991005544A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633001A (en) * 1993-03-19 1997-05-27 Medinvent Composition and a method for tissue augmentation
US5716631A (en) * 1995-09-29 1998-02-10 Rdn Therapeutics Inc. Long acting narcotic analgesics and antagonists
CN1126537C (zh) * 1996-05-23 2003-11-05 株式会社三养社 可局部给药,可生物降解和持续释放的用于治疗牙周炎的药物组合物及其制备方法
JP4642946B2 (ja) * 1996-12-20 2011-03-02 アルザ コーポレイション ゲル組成物および方法
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) * 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
JP4460892B2 (ja) 2001-06-21 2010-05-12 ジェネンテック インコーポレイテッド 徐放性組成物
RU2005102604A (ru) * 2002-07-03 2005-09-10 Перикор Сайенс, Инк. (Us) Композиция гиалуроновой кислоты и способы применения
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (de) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotisches Verabreichungssystem mit Kolbenanordnung
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2376522A4 (de) 2008-11-16 2013-12-25 Univ Texas Niederviskose hochkonzentrierte suspensionen
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663685A (en) * 1968-04-01 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US4169804A (en) * 1976-08-19 1979-10-02 Minnesota Mining And Manufacturing Company Magnetically responsive composite microparticle
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
EP0140255B1 (de) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Injektionen mit verzögerter Abgabe
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
JPS63624A (ja) * 1986-06-19 1988-01-05 Nec Corp 正規乱数発生方法
DE3626868A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung

Also Published As

Publication number Publication date
CA2067228A1 (en) 1991-04-24
CA2067228C (en) 2002-01-08
AU6623790A (en) 1991-05-16
EP0497846B1 (de) 1996-09-25
EP0497846A1 (de) 1992-08-12
US5614221A (en) 1997-03-25
DE69028710D1 (de) 1996-10-31
WO1991005544A1 (en) 1991-05-02
JPH05503921A (ja) 1993-06-24
JP3017801B2 (ja) 2000-03-13
SE8903503L (sv) 1991-04-24
AU632634B2 (en) 1993-01-07
DE69028710T2 (de) 1997-04-17
SE465950B (sv) 1991-11-25
SE8903503D0 (sv) 1989-10-23

Similar Documents

Publication Publication Date Title
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
ATE235889T1 (de) Mikropartikel aus chitosan-gelatin a
US5885615A (en) Pharmaceutical controlled release tablets containing a carrier made of cross-linked amylose and hydroxypropylmethylcellulose
EP1126881B1 (de) Mucoadhäsive polymere, deren verwendung sowie deren herstellungsverfahren
FR2613224B1 (fr) Forme posologique bicouche a liberation prolongee
PT97369A (pt) Processo para a preparacao de formulacoes farmaceutica na qual o sabor do medicamento e disfarcado por meio de revestimento do medicamento com uma membrana polimerica
ATE264671T1 (de) Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
ATE122879T1 (de) Verabreichungsformen für pharmaka.
NZ501950A (en) Medicinal compositions for application to mucosa
AU6786187A (en) Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
DK0706401T3 (da) Lægemiddelafgivelsessystem
ES2173641T3 (es) Composicion de derivados opiaceos para la fabricacion de medicamentos.
AR034640A1 (es) Composicion de liberacion sostenida y proceso para producirla
US20230090929A1 (en) Natural composition based on polymers to be electrospun, and method to prepare the same
ATE40292T1 (de) Verfahren zur herstellung von unilamellaren liposomen von grobem diameter, ihre pharmazeutische anwendung fuer die verkapselung von aktivem prinzip fuer die verzoegerte wirkstoffabgabe und vorrichtung hierfuer.
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
DE50014164D1 (de) Verfahren zur herstellung einer wasserunlöslichen amorphen retardmatrix
GB2305606A (en) Drug delivery composition for the nasal administration of antiviral agents
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
EP1288311A3 (de) Methode zum testen von wirkstoffen hinsichtlich der aktivierung von pax4 und der produktion von insulin produzierenden beta-zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties